PT1758914E - Novos derivados fluoroglicosídicos de pirazoles, medicamentos contendo estes compostos e sua utilização - Google Patents

Novos derivados fluoroglicosídicos de pirazoles, medicamentos contendo estes compostos e sua utilização Download PDF

Info

Publication number: PT1758914E
Authority: PT; Portugal
Prior art keywords: pyrazoles; compounds; medicaments containing; novel; fluoroglycoside derivatives
Prior art date: 2004-06-11

Application number

PT05746637T

Other languages

English (en)

Inventor

Heiner Glombik

Wendelin Frick

Hubert Heuer

Martin Bickel

Harm Brummerhop

Oliver Plettenburg

Stefan Theis

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-11

Filing date

2005-06-03

Publication date

2008-01-31

2005-06-03 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2008-01-31 Publication of PT1758914E publication Critical patent/PT1758914E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Diabetes (AREA)
Hematology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)

PT05746637T 2004-06-11 2005-06-03 Novos derivados fluoroglicosídicos de pirazoles, medicamentos contendo estes compostos e sua utilização PT1758914E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004028241A DE102004028241B4 (de)	2004-06-11	2004-06-11	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel

Publications (1)

Publication Number	Publication Date
PT1758914E true PT1758914E (pt)	2008-01-31

Family

ID=35355753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05746637T PT1758914E (pt)	2004-06-11	2005-06-03	Novos derivados fluoroglicosídicos de pirazoles, medicamentos contendo estes compostos e sua utilização

Country Status (34)

Country	Link
US (1)	US7820804B2 (pt)
EP (1)	EP1758914B1 (pt)
JP (1)	JP4996464B2 (pt)
CN (1)	CN100582116C (pt)
AR (1)	AR049393A1 (pt)
AU (1)	AU2005252329B2 (pt)
BR (1)	BRPI0510770A (pt)
CA (1)	CA2570042C (pt)
CR (1)	CR8773A (pt)
CY (1)	CY1107426T1 (pt)
DE (2)	DE102004028241B4 (pt)
DK (1)	DK1758914T3 (pt)
EC (1)	ECSP067054A (pt)
ES (1)	ES2296180T3 (pt)
HK (1)	HK1100411A1 (pt)
HR (1)	HRP20080023T3 (pt)
IL (1)	IL179757A (pt)
MA (1)	MA28653B1 (pt)
MX (1)	MXPA06013513A (pt)
MY (1)	MY143565A (pt)
NO (1)	NO20070176L (pt)
NZ (1)	NZ551948A (pt)
PE (1)	PE20060297A1 (pt)
PL (1)	PL1758914T3 (pt)
PT (1)	PT1758914E (pt)
RS (1)	RS50541B (pt)
RU (1)	RU2370499C2 (pt)
SI (1)	SI1758914T1 (pt)
TN (1)	TNSN06409A1 (pt)
TW (1)	TWI382030B (pt)
UA (1)	UA89787C2 (pt)
UY (1)	UY28955A1 (pt)
WO (1)	WO2005121161A1 (pt)
ZA (1)	ZA200608832B (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200637869A (en)	2005-01-28	2006-11-01	Chugai Pharmaceutical Co Ltd	The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
DE102005026762A1 (de)	2005-06-09	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
CA2652707A1 (en)	2006-05-19	2007-11-29	Taisho Pharmaceutical Co., Ltd.	C-phenyl glycitol compound
CA2655937A1 (en)	2006-06-29	2008-01-03	Taisho Pharmaceutical Co., Ltd.	C-phenyl 1-thioglucitol compound
MX2009001043A (es)	2006-08-08	2009-02-06	Sanofi Aventis	Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso.
DE102006053637B4 (de) *	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CN101611023A (zh)	2006-12-14	2009-12-23	大正制药株式会社	1－苯基1－硫代－d－山梨醇衍生物
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP5272395B2 (ja) *	2007-12-12	2013-08-28	セントラル硝子株式会社	４−デオキシ−４−フルオロ−ｄ−グルコース誘導体の製造方法
TW201014822A (en)	2008-07-09	2010-04-16	Sanofi Aventis	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
KR101338540B1 (ko) *	2008-08-28	2013-12-06	화이자 인코포레이티드	다이옥사-바이사이클로[3.2.1]옥테인-2,3,4-트라이올 유도체
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
JP5505741B2 (ja)	2009-02-23	2014-05-28	大正製薬株式会社	Ｓｇｌｔ１阻害剤としての４−イソプロピルフェニルグルシトール化合物
EP2298782A1 (en)	2009-08-26	2011-03-23	Sanofi-Aventis	Method for producing pyrazole glycoside derivatives
BR112012003973A2 (pt)	2009-08-26	2015-09-08	Sanofi Sa	hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso
WO2011039338A2 (en)	2009-10-02	2011-04-07	Sanofi-Aventis	Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
SI2496583T1 (sl)	2009-11-02	2015-02-27	Pfizer Inc.	Derivati dioksa-biciklo(3.2.1)oktan-2,3,4-triola
RS57926B1 (sr)	2009-11-13	2019-01-31	Astrazeneca Ab	Formulacije tablete sa trenutnim oslobađanjem
CA2987757C (en)	2009-11-13	2021-04-13	Astrazeneca Uk Limited	Bilayer tablet formulations
AU2010319438B2 (en)	2009-11-13	2015-05-21	Astrazeneca Uk Limited	Reduced mass metformin formulations
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
ES2546253T3 (es)	2010-08-20	2015-09-22	Taisho Pharmaceutical Co., Ltd.	Compuesto 4-isopropil-6-metoxifenilglucitol
WO2012023598A1 (ja)	2010-08-20	2012-02-23	大正製薬株式会社	４－イソプロピルフェニルグルシトール化合物の結晶形及びその製造方法
MX2013002146A (es)	2010-09-03	2013-04-03	Astrazeneca Uk Ltd	Formulaciones farmaceuticas que utilizan antioxidantes solubles en agua.
MX2013008372A (es)	2011-02-01	2013-08-12	Astrazeneca Uk Ltd	Formulaciones farmaceuticas que incluyen compuesto de amina.
WO2012120055A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683698B1 (de)	2011-03-08	2017-10-04	Sanofi	Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683701B1 (de)	2011-03-08	2014-12-24	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683705B1 (de)	2011-03-08	2015-04-22	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de)	2011-03-08	2014-12-24	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8895547B2 (en)	2011-03-08	2014-11-25	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8901114B2 (en)	2011-03-08	2014-12-02	Sanofi	Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8614195B2 (en) *	2011-04-14	2013-12-24	Novartis Ag	Glycoside derivatives and uses thereof
AR087701A1 (es) *	2011-08-31	2014-04-09	Japan Tobacco Inc	Derivados de pirazol con actividad inhibidora de sglt1
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
UA113086C2 (xx) *	2012-05-10	2016-12-12		Піразольні сполуки як інгібітори sglt1
TW201425326A (zh)	2012-10-05	2014-07-01	Lilly Co Eli	新穎脲化合物
RU2648467C2 (ru)	2013-02-04	2018-03-26	Тайсо Фармасьютикал Ко., Лтд.	Профилактическое или терапевтическое лекарственное средство для лечения запора
EP2774619B1 (de)	2013-03-04	2016-05-18	BioActive Food GmbH	Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen
AR098670A1 (es) *	2013-11-08	2016-06-08	Lilly Co Eli	Inhibidor de sglt1
EP2944311A1 (de)	2014-05-16	2015-11-18	BioActive Food GmbH	Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen
MX2020010433A (es) *	2018-04-04	2020-10-28	Japan Tobacco Inc	Compuestos de pirazol sustituidos con heteroarilo y uso farmaceutico de los mismos.
CA3121202A1 (en)	2018-11-30	2020-06-04	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2176600T3 (es) *	1996-12-26	2002-12-01	Tanabe Seiyaku Co	Derivado de la propiofenona y procedimientos para su preparacion.
DE60009929T2 (de) *	1999-08-31	2005-03-31	Kissei Pharmaceutical Co., Ltd., Matsumoto	Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
PH12000002657B1 (en) *	1999-10-12	2006-02-21	Bristol Myers Squibb Co	C-aryl glucoside SGLT2 inhibitors
ATE455785T1 (de) *	2000-11-02	2010-02-15	Ajinomoto Kk	Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
WO2002064839A2 (en) *	2001-02-14	2002-08-22	Tularik Inc.	Methods for the diagnosis and treatment of tumors employing the hepsin gene
KR100985502B1 (ko) *	2002-08-08	2010-10-05	깃세이 야쿠힌 고교 가부시키가이샤	피라졸 유도체,그것을 함유하는 의약 조성물, 그 의약용도 및 그 제조 중간체
JP2004137245A (ja) *	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja) *	2002-08-27	2011-01-05	キッセイ薬品工業株式会社	ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
EP1550668A4 (en) *	2002-10-04	2008-10-01	Kissei Pharmaceutical	PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION COMPRISING THE DERIVATIVE, MEDICINAL USE THEREOF, AND INTERMEDIATE ENTERING THE PRODUCTION THEREOF
WO2004050122A1 (ja) *	2002-12-04	2004-06-17	Kissei Pharmaceutical Co., Ltd.	高血糖症に起因する疾患の予防又は治療剤
DE10258008B4 (de) *	2002-12-12	2006-02-02	Sanofi-Aventis Deutschland Gmbh	Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
CA2529878C (en) *	2003-06-20	2012-11-20	Kissei Pharmaceutical Co., Ltd.	Pyrazole derivative, drug composition containing the same and production intermediate therefor

2004
- 2004-06-11 DE DE102004028241A patent/DE102004028241B4/de not_active Expired - Fee Related
2005
- 2005-06-03 RS RSP-2008/0017A patent/RS50541B/sr unknown
- 2005-06-03 PT PT05746637T patent/PT1758914E/pt unknown
- 2005-06-03 NZ NZ551948A patent/NZ551948A/en not_active IP Right Cessation
- 2005-06-03 SI SI200530142T patent/SI1758914T1/sl unknown
- 2005-06-03 CN CN200580019067A patent/CN100582116C/zh not_active Expired - Fee Related
- 2005-06-03 WO PCT/EP2005/005959 patent/WO2005121161A1/de active Application Filing
- 2005-06-03 MX MXPA06013513A patent/MXPA06013513A/es active IP Right Grant
- 2005-06-03 DE DE502005002056T patent/DE502005002056D1/de active Active
- 2005-06-03 AU AU2005252329A patent/AU2005252329B2/en not_active Ceased
- 2005-06-03 DK DK05746637T patent/DK1758914T3/da active
- 2005-06-03 PL PL05746637T patent/PL1758914T3/pl unknown
- 2005-06-03 BR BRPI0510770-9A patent/BRPI0510770A/pt not_active IP Right Cessation
- 2005-06-03 RU RU2007101154/04A patent/RU2370499C2/ru not_active IP Right Cessation
- 2005-06-03 JP JP2007526254A patent/JP4996464B2/ja not_active Expired - Fee Related
- 2005-06-03 UA UAA200700259A patent/UA89787C2/ru unknown
- 2005-06-03 EP EP05746637A patent/EP1758914B1/de active Active
- 2005-06-03 ES ES05746637T patent/ES2296180T3/es active Active
- 2005-06-03 CA CA2570042A patent/CA2570042C/en not_active Expired - Fee Related
- 2005-06-09 MY MYPI20052616A patent/MY143565A/en unknown
- 2005-06-09 TW TW094118973A patent/TWI382030B/zh not_active IP Right Cessation
- 2005-06-10 UY UY28955A patent/UY28955A1/es unknown
- 2005-06-10 PE PE2005000666A patent/PE20060297A1/es not_active Application Discontinuation
- 2005-06-13 AR ARP050102406A patent/AR049393A1/es not_active Application Discontinuation
2006
- 2006-10-24 ZA ZA200608832A patent/ZA200608832B/en unknown
- 2006-11-27 CR CR8773A patent/CR8773A/es not_active Application Discontinuation
- 2006-11-30 IL IL179757A patent/IL179757A/en not_active IP Right Cessation
- 2006-12-05 MA MA29515A patent/MA28653B1/fr unknown
- 2006-12-06 US US11/567,410 patent/US7820804B2/en not_active Expired - Fee Related
- 2006-12-08 EC EC2006007054A patent/ECSP067054A/es unknown
- 2006-12-08 TN TNP2006000409A patent/TNSN06409A1/en unknown
2007
- 2007-01-10 NO NO20070176A patent/NO20070176L/no not_active Application Discontinuation
- 2007-07-31 HK HK07108324.3A patent/HK1100411A1/xx not_active IP Right Cessation
2008
- 2008-01-16 HR HR20080023T patent/HRP20080023T3/xx unknown
- 2008-02-04 CY CY20081100139T patent/CY1107426T1/el unknown

Also Published As

Publication number	Publication date
EP1758914A1 (de)	2007-03-07
RS50541B (sr)	2010-05-07
TWI382030B (zh)	2013-01-11
CN1964984A (zh)	2007-05-16
AU2005252329B2 (en)	2011-02-10
ZA200608832B (en)	2008-05-28
US20070197623A1 (en)	2007-08-23
TW200610527A (en)	2006-04-01
SI1758914T1 (sl)	2008-04-30
ES2296180T3 (es)	2008-04-16
TNSN06409A1 (en)	2008-02-22
HRP20080023T3 (en)	2008-06-30
CN100582116C (zh)	2010-01-20
WO2005121161A1 (de)	2005-12-22
ECSP067054A (es)	2007-01-26
DK1758914T3 (da)	2008-03-17
DE102004028241B4 (de)	2007-09-13
IL179757A0 (en)	2007-05-15
CA2570042C (en)	2013-01-15
JP4996464B2 (ja)	2012-08-08
PL1758914T3 (pl)	2008-04-30
PE20060297A1 (es)	2006-05-25
US7820804B2 (en)	2010-10-26
EP1758914B1 (de)	2007-11-21
CY1107426T1 (el)	2012-12-19
UA89787C2 (ru)	2010-03-10
DE102004028241A1 (de)	2006-01-05
RU2370499C2 (ru)	2009-10-20
CA2570042A1 (en)	2005-12-22
AU2005252329A1 (en)	2005-12-22
RU2007101154A (ru)	2008-07-20
UY28955A1 (es)	2006-01-31
CR8773A (es)	2008-02-28
NO20070176L (no)	2007-03-09
MXPA06013513A (es)	2007-03-01
MA28653B1 (fr)	2007-06-01
IL179757A (en)	2010-12-30
NZ551948A (en)	2010-04-30
BRPI0510770A (pt)	2007-11-20
AR049393A1 (es)	2006-07-26
DE502005002056D1 (de)	2008-01-03
MY143565A (en)	2011-05-31
JP2008501745A (ja)	2008-01-24
HK1100411A1 (en)	2007-09-21

Publication	Publication Date	Title
IL179757A0 (en)	2007-05-15	Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
HK1082744A1 (en)	2006-06-16	Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
ZA200608028B (en)	2009-03-25	Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
IL181524A (en)	2013-04-30	Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs
ZA200606792B (en)	2007-12-27	Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
IL178297A0 (en)	2007-02-11	Hydrazide derivatives and pharmaceutical compositions containing the same
IL182664A0 (en)	2007-09-20	Triazole derivatives and pharmaceutical compositions containing the same
IL179754A0 (en)	2007-05-15	Pyrazole derivatives, compositions containing such compounds and methods of use
IL179496A0 (en)	2007-05-15	Triazole derivatives and pharmaceutical compositions containing the same
IL181964A0 (en)	2007-07-04	Medicaments comprising carbonyl compounds, and the use thereof
IL177450A0 (en)	2006-12-10	Substituted pyrazoline compounds, their preparation and use as medicaments
AU2003262262A1 (en)	2004-03-19	Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
IL190754A0 (en)	2008-11-03	Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
ZA200608029B (en)	2008-12-31	Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL177073A0 (en)	2006-12-10	Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
IL177496A0 (en)	2006-12-10	Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
HK1089671A1 (en)	2006-12-08	Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
IL184008A0 (en)	2007-10-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
ZA200506422B (en)	2007-02-28	Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
ZA200803335B (en)	2009-10-28	Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
ZA200704650B (en)	2008-12-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
SI1747201T1 (sl)	2009-04-30	Derivati 2H- ali 3-H-benzo (e)indazol-1-il karbamata, njihova priprava in njihova terapevtska uporaba
IL181729A0 (en)	2007-07-04	Imidazole derivatives and pharmaceutical compositions containing the same
ZA200606605B (en)	2008-02-27	Substituted pyrazoline compounds, their preparation and use as medicaments
ZA200602991B (en)	2007-09-26	Novel long-working beta-2-agonists and use thereof as medicaments